Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA

Assessing the Treatment of Patients With Neuropathic Pain Using LYRICA; A Non Interventional Post-marketing Study (NI-PMS)

A Non-Interventional, Post-Marketing Surveillance (NI-PMS) study whose objectives were to assess the impact of pregabalin on subjects' pain, quality of sleep, and their general wellbeing, as well as the tolerance and safety of pregabalin in subjects with neuropathic pain.

A non-interventional study of patients diagnosed with neuropathic pain administered pregabalin and followed up for 8 weeks

Inclusion Criteria:

• Clinical diagnosis of neuropathic pain and inclusion according to the current Summary of Product Characteristics.

Exclusion Criteria:

• The patients were excluded according to the current Summary of Product Characteristics.